BioSig AI Sciences
Westport, US · Founded 2020 · Delaware corporation
Founders & leadership
BioSig AI Sciences was founded in 2020 by Kenneth Londoner.
KL
Kenneth LondonerinSole DirectorKenneth Londoner founded BioSig Technologies in 2009 and serves as its CEO and chairman. He has held leadership roles at cardiac software company NewCardio and served as director at medical device firm Alliqua BioMedical, while also managing Endicott Management Partners, a corporate development advisory firm he established in 2004.
Reported raises · per SEC filings
Form D private placements$2.2M disclosed across 2 rounds · 2023
▶$495KraisedJul 2023 · 4 investors · Other Health CareRule 506(b)
▶$495KraisedJul 2023 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Kenneth LondonerDirector
- Offering amount
- $495K
- Amount sold
- $495K
- Sales commissions
- $47.3K
- Placement agents
- Laidlaw & Company (UK) Ltd.
- First sale
- Jul 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$1.7MraisedJul 2023 · 16 investors · Other Health CareRule 506(b)
▶$1.7MraisedJul 2023 · 16 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Kenneth LondonerDirector
- Offering amount
- $1.7M
- Amount sold
- $1.7M
- Sales commissions
- $142.6K
- Placement agents
- Laidlaw & Company (UK) Ltd.
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded BioSig AI Sciences?
- BioSig AI Sciences was founded by Kenneth Londoner in 2020.
- How much funding has BioSig AI Sciences raised?
- BioSig AI Sciences has disclosed $2.2M raised across 2 rounds.
- Where is BioSig AI Sciences headquartered?
- BioSig AI Sciences is headquartered in Westport, US.